Artificial Intelligence

INOVIO's promising non-surgical treatment for a rare disease faces FDA scrutiny, casting doubt on its fast-track approval and impacting patient hopes.

The AI investment frenzy is shifting from GPUs to the physical world of power, cooling, and real estate, creating a new class of high-value companies.

With a new CEO and a booming market, mobile care provider instED is poised for major expansion. Here's what the move means for the future of healthcare.

SoftBank is buying digital infrastructure giant DigitalBridge for $4B, a bold move to own the data centers and fiber needed to power its AI ambitions.

Syntiant unveils ultra-thin AI chips for hearables and smart remotes, aiming to dominate the booming market for miniaturized intelligent devices.

Genmab discontinues its 'encouraging' lung cancer drug, acasunlimab, in a bold strategic pivot to accelerate its most promising late-stage assets.

Professional Diversity Network invests millions in an AI crypto token, a risky move signaling a dramatic pivot into the volatile world of Web3 finance.

A new AI assistant is being piloted in the UAE, promising to cut doctor paperwork by 50% and give patients more face-to-face attention.

A pivotal trial for an acute myeloid leukemia drug is delayed for a promising reason: patients are surviving longer than anticipated, fueling cautious optimism.

The investment firm sheds its medical focus, adopting a new name and a broader mandate to chase cross-sector opportunities in the booming AI market.

The InsurTech firm is shedding non-core units to slash debt by over 50% and double down on its AI platforms, RELI Exchange and 5minuteinsure.com.

Israeli innovator Foresight gets a major nod from Audi, showcasing its all-weather 3D vision system that could redefine autonomous vehicle safety.

Cleveland expands its AI security robot program, citing reduced crime. But as other cities watch, questions of cost, privacy, and effectiveness emerge.

With promising new drugs for obesity and liver disease, clinical-stage MetaVia steps into the spotlight at a key industry conference, facing giants and high hopes.

Azenta divests its medical refrigeration unit to streamline its portfolio, signaling a strategic pivot to its high-growth multiomics and sample management services.

With a promising schizophrenia drug stalled by FDA requirements and finances tight, Reviva Pharmaceuticals' upcoming presentation is more than just a talk.

Semiconductor metrology leader Nova adds seasoned investor Rami Hadar to its board, signaling a strategic push to accelerate growth and innovation.

iQSTEL caps a transformational year with a NASDAQ uplist, record revenue, and a strategic pivot to Fintech and Cybersecurity, eyeing a $1B future.

A Korean AI startup raised $854K for a gesture-control ring, betting its enterprise-grade tech can unlock the future of post-touch computing.

After resolving a key manufacturing issue, Unicycive has resubmitted its kidney drug NDA, offering new hope for dialysis patients with a lower pill burden.